CT
MRNA icon

Clearstead Trust’s Moderna MRNA Stock Holding History

Clearstead Trust’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.88K Hold
96
– – ﹤0.01% 755
2025
Q4 		$2.83K Sell
96
-78
-45% -$2.12K ﹤0.01% 857
2025
Q3 		$4.5K Buy
174
+162
+1,350% +$4.52K ﹤0.01% 791
2025
Q2 		$332 Sell
12
-108
-90% -$2.84K ﹤0.01% 1406
2025
Q1 		$3.4K Buy
+120
New +$4.26K ﹤0.01% 689
2024
Q4 		– Sell
-10
Closed -$668 – 435
2024
Q3 		$668 Hold
10
– – ﹤0.01% 409
2024
Q2 		$1.19K Hold
10
– – ﹤0.01% 420
2024
Q1 		$1.07K Hold
10
– – ﹤0.01% 416
2023
Q4 		$995 Hold
10
– – ﹤0.01% 402
2023
Q3 		$1.03K Buy
+10
New +$1.11K ﹤0.01% 426

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return